Select a Region North America

Oncology and Hematology

Oncology and hematology are extremely complex, crowded and chaotic therapeutic areas.

Manufacturers of these high-science brands are often faced with:

  • Unprecedented pressure to accelerate their speed to market,
  • Securing patient access and affordability,
  • Creating compelling stakeholder engagement in a hybrid world,
  • Changing patient journeys
  • Evolving FDA interactions,
  • And much more.

The first five years of commercialization typically costs $265M. Manufacturers should not be forced to lose ownership, sacrifice their company value or invest more than $200M to commercialize on their own. Instead, they must decide how to develop the necessary infrastructure to launch, shape the market and build industry relationships.

Tumor Types Drive Oncology Product Launch Strategies  

Unlike traditional launch plans designed for blockbuster products, oncology and hematology therapy commercialization requires agility.

  • Different tumor types and the form of therapy require distinct commercialization strategies.
  • Patients with lung, breast, or colon cancer often undergo long-term, multi-faceted treatment following early detection, requiring sustained patient services and financial support. In contrast, pancreatic cancer patients typically face urgent needs due to late-stage diagnosis.

At EVERSANA, we developed an life sciences commercialization model specific to product and patient needs using a system of archetypes that consider therapy type, how the product is administered and the impact of the therapy on the patient journey.

Leveraging our award-winning model commercialization model, coupled with our deep bench of oncology experts, EVERSANA partners with manufacturers to develop a customized, comprehensive go-to-market strategy. Click here to learn more about EVERSANA ONCOLOGY Commercialization™. 

Explore the benefits of EVERSANA’s innovative commercialization model.

EVERSANA's Oncology Experts

Anne Marie Robertson | Oncology Expert

Anne Marie Robertson
EVP, Oncology
Read Bio

Suzanne Greenwood | Oncology Expert

Suzanne Greenwood, RN, BSN
CCO, Oncology
Read Bio

Barry Vucsko | Oncology Expert

Barry Vucsko
SVP, Strategic Development
Read Bio

Recent News

お問い合わせ

Have a question or interested in scheduling a call to learn more about our business solutions?

Fill out the form and we’ll get back to you promptly.